Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
New York University · with National Institute of Dental and Craniofacial Research (NIDCR) · NCT07095608
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- September 1, 2025
- Record last updated
- November 21, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a prospective study involving human participants. Pressure and stretch sensitivity measures between oral cancer patients and healthy subjects will be compared. Pain stimulation will be conducted on the site of the cancer in 40 oral cancer patients, and on the tongue in 40 healthy volunteers, using pressure and stretch sensitivity tests.
Being studied: Pressure and stretch sensitivity testing
Conditions: Oral Cancer; Squamous Cell Carcinoma
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
For healthy subjects to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female, at least 18 years of age
- In good general health as evidenced by medical history
For oral cancer patients to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female, at least 18 years of age
- Biopsy-proven squamous cell carcinoma (SCC) of the oral cavity that requires surgical resection
- Lesion is at least 1 cm in greatest surface dimension
Exclusion Criteria
- Healthy subjects who meet any of the following criteria will be excluded from participation in this study:
- Clinically and/or histologically proven oral pre-cancer, oral cancer
- Pregnancy or lactation (Female subjects of child-bearing potential will have a rapid urine pregnancy test)
- Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.
Oral cancer patients who meet any of the following criteria will be excluded from participation in this study:
- History of prior surgical, chemotherapeutic, or radiation treatment for head and neck cancer
- Pregnancy or lactation
- Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.
For participants with impaired kidney function (chronic kidney/renal disease) who wish to participate in the proposed research study, consultation with their primary care provider will be done prior to enrollment to determine safety
Recruiting US locations
NYU College of Dentistry
New York, NY 10010
Site contact: Yatendra Mulpuri, PhD · 424-230-4222 · ym2891@nyu.edu
Study contacts (from the official record)
- Yatendra Mulpuri, PhD · 424-230-4222 · ym2891@nyu.edu
- Mariana Bucovsky, MHA · 212-998-9389 · mb10357@nyu.edu
Similar studies in New York
All healthy volunteers studies in New York →- RecruitingHealthy volunteers
Using Middle School Science Teachers to Address Cancer Health Disparities
Weill Medical College of Cornell University
- Location
- New York, NY + 1 other US site
- Eligibility basics
- Ages 10+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Staten Island, NY + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- East Syracuse, NY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1